- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03055637
Evaluation of the Incidence of Palatal Fistula in Furlow Double-opposing Z-plasty vs. Two-flap Palatoplasty for Cleft Palate Repair
February 14, 2017 updated by: Sarah Moustafa Mahmoud Fahmy El-Youtti
Evaluation of the incidence of palatal fistula in Furlow double-opposing z-plasty versus two-flap palatoplasty for cleft palate repair.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Up to 6 hours before the scheduled arrival time, formula-fed babies may be given formula.
Up to 4 hours before the scheduled arrival time, breastfed babies may nurse.
Up to 2 hours before the scheduled arrival time, give only clear liquids.
Clear liquids include water, Pedialyte®, Kool-Aid® and juices you can see through, such as apple or white grape juice.
In the 2 hours before the scheduled arrival time, give nothing to eat or drink.
Induction of general anaesthesia will be administered followed by local anaethesia.
Then, Surgical prodecure will be done either following the conventional two flap palatoplasty technique or the Furlow double-opposing z-plasty technique.
Study Type
Interventional
Enrollment (Anticipated)
32
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 months to 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age of Repair from 9 to 12 months.
- Isolated Cleft Palate
- Operation time should nearly be the same for all patients
- Surgical skills done by same surgeon
- Both sexes
Exclusion Criteria:
- Patients with hypoplasia of palatal tissue.
- Patients with associated anomalies.
- Patients with associated syndromes.
- Other types of cleft palate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: patients with isolated cleft palate
Patients requiring isolated cleft palate repair
|
* Furlow, (1986) has described a technique for palatoplasty combining the principles of mucosal lengthening with creation of an intact muscular sling in the palate with double opposing Z-plasty.
On the soft palate, mirror image Z-plasties are drawn, one for the nasal musoca and the other oral flaps, the nasal flaps are developed and closed first .The oral flaps are then approximated.
The defect created usually closes readily.
The closure lines of the two soft plate layers do not overlap, minimizing the potential for contracture.
Also, this repair permits closure of the hard palate without lateral incisions
design the 2-flap palatoplasty, with a 2-layer closure in the hard palate and 3-layer closure in the soft palate,
|
Active Comparator: Patients with isolated cleft palate
Patients requiring isolated cleft palate repair
|
* Furlow, (1986) has described a technique for palatoplasty combining the principles of mucosal lengthening with creation of an intact muscular sling in the palate with double opposing Z-plasty.
On the soft palate, mirror image Z-plasties are drawn, one for the nasal musoca and the other oral flaps, the nasal flaps are developed and closed first .The oral flaps are then approximated.
The defect created usually closes readily.
The closure lines of the two soft plate layers do not overlap, minimizing the potential for contracture.
Also, this repair permits closure of the hard palate without lateral incisions
design the 2-flap palatoplasty, with a 2-layer closure in the hard palate and 3-layer closure in the soft palate,
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Incidence of fistula
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
February 19, 2017
Primary Completion (Anticipated)
May 19, 2017
Study Completion (Anticipated)
May 19, 2017
Study Registration Dates
First Submitted
February 14, 2017
First Submitted That Met QC Criteria
February 14, 2017
First Posted (Actual)
February 16, 2017
Study Record Updates
Last Update Posted (Actual)
February 16, 2017
Last Update Submitted That Met QC Criteria
February 14, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Congenital Abnormalities
- Musculoskeletal Diseases
- Stomatognathic Diseases
- Mouth Diseases
- Pathological Conditions, Anatomical
- Mouth Abnormalities
- Stomatognathic System Abnormalities
- Jaw Abnormalities
- Jaw Diseases
- Maxillofacial Abnormalities
- Craniofacial Abnormalities
- Musculoskeletal Abnormalities
- Fistula
- Cleft Palate
Other Study ID Numbers
- 28902051202049
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fistula of Soft Palate (Disorder)
-
Catharina Ziekenhuis EindhovenCompletedIntubation Complication | Abrasion of Soft PalateNetherlands
-
University Hospital, Basel, SwitzerlandRecruiting
-
TauTona GroupCompleted
-
CEL-SCI CorporationTeva Branded Pharmaceutical Products R&D, Inc.; Orient Europharma Co., Ltd.CompletedSquamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Soft PalateSpain, Taiwan, United States, United Kingdom, Romania, India, Croatia, Belarus, Hungary, Bosnia and Herzegovina, Russian Federation, Austria, Canada, France, Israel, Italy, Malaysia, Poland, Serbia, Sri Lanka, Thailand, Turkey, Ukraine
-
Lagos State UniversityUniversity of Lagos, NigeriaRecruitingCleft Palate | Cleft Lip and Cleft Palate | Cleft Lip, Cleft Alveolus and Cleft PalateNigeria
-
University Hospital, Basel, SwitzerlandUnity Health Toronto; Mount Sinai Hospital, Canada; Women's College Hospital; St...CompletedComplex Anal FistulaSwitzerland
-
Assiut UniversityNot yet recruitingRisk Scoring System for Prediction of Pancreatic Fistula Post PD
-
Ai PengRecruitingArteriovenous Fistula Flow Monitoring | Early Detection of Complications of Arteriovenous Fistula | VoiceprintChina
-
Jiangang SongWithdrawn
-
IRCCS San RaffaeleRecruitingComplication of Surgical Procedure | Complication,Postoperative | Esophagus; Fistula | Fistula;RectalItaly
Clinical Trials on Furlow double opposing z-plasty
-
University of FloridaUniversity of Sao PauloCompleted
-
Hams Hamed AbdelrahmanCompletedCleft Palate, Unilateral, CompleteEgypt
-
Hospital Universitario Reina Sofia de CordobaCompletedCarpal Tunnel SyndromeSpain
-
Dow University of Health SciencesUnknown
-
Abanoub emad fayezNot yet recruiting
-
Fayoum UniversityEnrolling by invitation
-
National Institute of Integrative Medicine, AustraliaUnknown